Implementing Precision Medicine in cOmmunity HospiTALs
Recruiting now · Not applicable
Conditions studied: Metastatic Cancer
In brief
This is a prospective biomarker study that aims at demonstrating the impact of liquid biopsy to deliver better treatment for cancer patients with metastatic disease managed in the community setting
Key facts
- Study ID
- NCT05283044
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
- People needed
- 10000
- Starts
- 2022-06-29
- Expected to finish
- 2030-04-15
- Last updated by the study team
- 2025-06-25
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Participants are eligible to be included in the study only if they meet all of the following criteria:
- Age ≥ 18 years
- Histology: solid malignant tumor
- Locally advanced/unresectable and/or metastatic (for prostate cancer: castration resistant prostate cancer, for RH+/HER2- breast cancer: prior treatment with endocrine therapy plus anti-CDK4/6 inhibitor)
- Eastern Cooperative Oncology Group (ECOG) performance status < 2
- Measurable disease as per RECIST criteria
- Patient with a social security in compliance with the French law relating to biomedical research (Article L.1121-11 of French Public Health Code)
- Voluntary signed and dated written informed consent prior to any study specific procedure.
You may not qualify if…
- Participants will be excluded from the study if they meet any of the following criteria:
- Radiological evidence of symptomatic or progressive brain metastases
- Previous or current malignancies of others histologies within the last 2 years, with the exception of in situ carcinoma of the cervix, and adequately treated basal cell or squamous cell carcinoma of the skin and prostate cancer
- Any condition which in the Investigator's opinion makes it undesirable for the subject to participate in a clinical trial or which would jeopardize compliance with the protocol
- Patient under guardianship or deprived of his liberty by a judicial or administrative decision or incapable of giving its consent
- Minors (Age < 18 years)
- Pregnant or breast-feeding women
- Previous enrollment in the present study.
Where it is running
- CH de la Côte Basque — Bayonne, France (enrolling)
- CH de Bligny — Bligny, France (enrolling)
- Hôpital de la source - CHR d'Orléans — Orléans, France (enrolling)
- Hôpital Saint-Joseph — Paris, France (enrolling)
- Institut Mutualiste Montsouris — Paris, France (enrolling)
- Groupement Hospitalier Diaconesses-Croix — Paris, France (enrolling)
- Centre Hospitalier — Pau, France (enrolling)
- Centre Eugène Marquis — Rennes, France (enrolling)
- HIA Bégin — Saint-Mandé, France (enrolling)
- Hôpital Nord-Ouest Villefranche-sur-Saône — Villefranche-sur-Saône, France (enrolling)
- CH Sud Francilien — Corbeil-Essonnes, France (enrolling)
- CHU de La Réunion — La Réunion, France (enrolling)
- Hôpital Américain — Neuilly-sur-Seine, France (enrolling)
- Polyclinique Bordeaux Nord Aquitaine — Bordeaux, France
- Clinique Kuindo Magnin — Noumea, New Caledonia
- CH Annecy Genevois — Épagny, France
- GHM de Grenoble — Grenoble, France
- Hôpitaux Privés de la Loire — Saint-Etienne, France
- Clinique Saint-Jean l'ermitage — Melun, France
- CHPF — Pirae, French Polynesia
- Hôpital Foch — Suresnes, France
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.